Comments
Covaxin, the first indigenous vaccine for Covid19 developed by Bharat Biotech and ICMR, has received government approval for emergency use in children between 12-18 years of age.
Disclosing this in a release on Saturday, Hyderabad-based Bharat Biotech said:
"We have documented excellent safety and immunogenicity data readouts in children."
Covaxin is formulated 'uniquely' such that the same dosage can be administered to adults and children, it said.
Covaxin has established a "proven" record for safety and efficacy in adults for the original variant and subsequent variants.
"We look forward for Covaxin to provide similar levels of protection for adults and children alike, it added.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.